Lauren Roth

King & Spalding

+ Follow Contact

Latest Posts › Regulatory Requirements

Share:

FDA Publishes More Than 200 Complete Response Letters (CRLs) With More to Come

On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in response to applications submitted to the FDA for approval of drugs or biological...more

7/14/2025 / Capital Markets , Compliance , Disclosure Requirements , Drug Approvals , Food and Drug Administration (FDA) , Investors , Pharmaceutical Industry , Regulatory Requirements , Securities Litigation , Shareholders

FDA Issues Two Guidances For the Device Q-Sub Process

CDRH and CBER Release Final Guidance for the Q-Submission Program and Draft Guidance for PreSTAR - On May 29, 2025, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) and Center...more

6/5/2025 / Compliance , Draft Guidance , Food and Drug Administration (FDA) , Government Agencies , Medical Devices , New Guidance , Regulatory Agenda , Regulatory Oversight , Regulatory Requirements , Rulemaking Process

New Executive Order Promotes Domestic Production of Critical Medicines

On May 5, 2025, President Donald J. Trump issued Executive Order (“EO”) 14293 entitled Regulatory Relief to Promote Domestic Production of Critical Medicines. The EO directs the U.S. Food and Drug Administration (“FDA”), U.S....more

5/12/2025 / Environmental Protection Agency (EPA) , Executive Orders , Food and Drug Administration (FDA) , National Security , Pharmaceutical Industry , Regulatory Reform , Regulatory Requirements , Supply Chain , Tariffs , Trump Administration

3 Results

View per page

Page: of 1